EDGAR Filing Documents for 0001126234-13-000118

Form 8-K - Current report:

SEC Accession No. 0001126234-13-000118

Filing Date

2013-08-14

Accepted

2013-08-14 17:56:17

Documents

Period of Report

2013-08-14

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	nlnk-20130814x8k.htm	8-K	34735
2	CHARLES LINK AMENDMENT	nlnk-20130814x8kxex101.htm	EX-10.1	20561
3	NICHOLAS VAHANIAN AMENDMENT	nlnk-20130814x8kxex102.htm	EX-10.2	21107
4	GORDON LINK AMENDMENT	nlnk-20130814x8kxex103.htm	EX-10.3	16965
5	W. JAY RAMSEY AMENDMENT	nlnk-20130814x8kxex104.htm	EX-10.4	16840
	Complete submission text file	0001126234-13-000118.txt		111408

Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010

Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555

NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 131039350
SIC: 2834 Pharmaceutical Preparations